We can talk about elevating the patient’s voice in clinical research, or we can listen. So let’s listen! In this clip, you’ll hear from both current and past clinical trial participants. They share their first encounters with clinical research and the reasons they decided to participate. This compilation is from a recent Velocity Participant Advisory … Read more
Enjoy a virtual tour of Velocity’s Durham, NC site, which showcases many of the features and standard equipment present at Velocity sites worldwide. Standard Velocity site features: Private exam rooms Comfortable patient reception areas Facilities for extended-stay PK studies Ample parking Secure monitoring rooms and workstations equipped with phones and high-speed internet Individual and secure … Read more
“Next to clean water, vaccines are probably responsible for more saved lives than anything else we’ve done in medicine.” -Mark Turner, MD, Vaccine CARE Council Leader and Velocity Principal Investigator in Boise, ID. Given the constant evolution of viruses and the massive medical and economic burdens imposed by viral diseases, vaccine research remains a global … Read more
Beth Safirstein, MD, leads a site that was recently recognized by a top 10 pharma Sponsor as a leading U.S. enroller of diverse patients. As the chair of the CNS CARE Council, Dr. Safirstein is one of the expert Principal Investigators who will inform the way Velocity sites shape and share best practices to reach … Read more
“Clinical research is really the only opportunity we have to give our patients some hope and some perspective that their disease will one day be treatable.” Nadege Gunn, MD, CPI, has consistently championed community engagement and physician referrals to drive successful clinical trial enrollment at her site in Waco, TX. As a MASH CARE Council … Read more
Velocity recently asked some key employees to come together and discuss a wide array of issues impacting diversity, equity, and inclusion (DEI) in trials. Velocity’s ongoing goals are to share best practices, identify and address shortcomings, and bring as many perspectives and viewpoints to the table as possible to advance clinical trials and deliver vital … Read more
Shishir Khetan, MD, is a Principal Investigator and Senior Medical Director at Velocity. He’s also a leading expert for the Cardiometabolic CARE Council. But as he explains in this video, he’s excited about the opportunities the CARE Council model is creating for investigators. Through expert knowledge exchange — including mentoring and training opportunities provided by … Read more
Heart disease remains the leading cause of death worldwide. The proliferation of heart issues — paired with lifestyle factors that complicate patient recruitment and study design — reflect an urgent need for expert-led clinical trials. Moreover, intersections among heart health and metabolic research offer promising opportunities to confront diseases affecting a growing, aging population, and … Read more
The global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rising. In light of the stark unmet needs in liver disease treatment — particularly for metabolic dysfunction-associated steatohepatitis (MASH) — there’s a pressing need for more sites equipped to effectively support advanced liver disease research. As Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG, mentions … Read more
Évelyne Newton and Sylwia Kołodziej recently made the journey overseas to join our CARE Council summit in Durham, NC. Along with dozens of our physicians and operational, commercial, and recruitment leaders, they helped define a strategy to extend the reach of new and existing CARE Councils. As they mention in this video, by enhancing the … Read more